Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium

Alice H. Hsu, Michelle A. Lum, Kang Sup Shim, Peter J. Frederick, Carl D. Morrison, Baojiang Chen, Subodh M Lele, Yuri M. Sheinin, Takiko Daikoku, Sudhansu K. Dey, Gustavo Leone, Adrian R Black, Jennifer D Black

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Protein kinase C (PKC) isozymes are commonly recognized as oncoproteins based on their activation by tumor-promoting phorbol esters. However, accumulating evidence indicates that PKCs can be inhibitory in some cancers, with recent findings propelling a shift in focus to understanding tumor suppressive functions of these enzymes. Here, we report that PKCα acts as a tumor suppressor in PI3K/AKT-driven endometrial cancer. Transcriptional suppression of PKCα is observed in human endometrial tumors in association with aggressive disease and poor prognosis. In murine models, loss of PKCα is rate limiting for endometrial tumor initiation. PKCα tumor suppression involves PP2A-family-dependent inactivation of AKT, which can occur even in the context of genetic hyperactivation of PI3K/AKT signaling by coincident mutations in PTEN, PIK3CA, and/or PIK3R1. Together, our data point to PKCα as a crucial tumor suppressor in the endometrium, with deregulation of a PKCα→PP2A/PP2A-like phosphatase signaling axis contributing to robust AKT activation and enhanced endometrial tumorigenesis. Hsu et al. find that PKCα is frequently lost in human and murine endometrial tumors and that PKCα deficiency enhances PI3K/AKT-driven endometrial neoplasia. PKCα suppresses aberrant AKT activity via a PP2A family phosphatase-dependent mechanism. Thus, PKCα loss appears to cooperate with PI3K/AKT perturbations to hyperactivate AKT and promote endometrial tumorigenesis.

Original languageEnglish (US)
Pages (from-to)655-669
Number of pages15
JournalCell Reports
Volume24
Issue number3
DOIs
StatePublished - Jul 17 2018

Fingerprint

Crosstalk
Endometrium
Phosphatidylinositol 3-Kinases
Protein Kinase C
Tumors
Neoplasms
Phosphoric Monoester Hydrolases
Carcinogenesis
Chemical activation
Protein C Deficiency
Deregulation
Oncogene Proteins
Phorbol Esters
Endometrial Neoplasms
Isoenzymes
Association reactions
Mutation
Enzymes

Keywords

  • AKT
  • Id1
  • PI3K
  • PKC
  • PKCα
  • PP2A family
  • PTEN
  • endometrial cancer
  • endometrium
  • tumor suppression

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Hsu, A. H., Lum, M. A., Shim, K. S., Frederick, P. J., Morrison, C. D., Chen, B., ... Black, J. D. (2018). Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium. Cell Reports, 24(3), 655-669. https://doi.org/10.1016/j.celrep.2018.06.067

Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium. / Hsu, Alice H.; Lum, Michelle A.; Shim, Kang Sup; Frederick, Peter J.; Morrison, Carl D.; Chen, Baojiang; Lele, Subodh M; Sheinin, Yuri M.; Daikoku, Takiko; Dey, Sudhansu K.; Leone, Gustavo; Black, Adrian R; Black, Jennifer D.

In: Cell Reports, Vol. 24, No. 3, 17.07.2018, p. 655-669.

Research output: Contribution to journalArticle

Hsu, AH, Lum, MA, Shim, KS, Frederick, PJ, Morrison, CD, Chen, B, Lele, SM, Sheinin, YM, Daikoku, T, Dey, SK, Leone, G, Black, AR & Black, JD 2018, 'Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium', Cell Reports, vol. 24, no. 3, pp. 655-669. https://doi.org/10.1016/j.celrep.2018.06.067
Hsu AH, Lum MA, Shim KS, Frederick PJ, Morrison CD, Chen B et al. Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium. Cell Reports. 2018 Jul 17;24(3):655-669. https://doi.org/10.1016/j.celrep.2018.06.067
Hsu, Alice H. ; Lum, Michelle A. ; Shim, Kang Sup ; Frederick, Peter J. ; Morrison, Carl D. ; Chen, Baojiang ; Lele, Subodh M ; Sheinin, Yuri M. ; Daikoku, Takiko ; Dey, Sudhansu K. ; Leone, Gustavo ; Black, Adrian R ; Black, Jennifer D. / Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium. In: Cell Reports. 2018 ; Vol. 24, No. 3. pp. 655-669.
@article{71fa461742884e88badf979a036fbc1e,
title = "Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium",
abstract = "Protein kinase C (PKC) isozymes are commonly recognized as oncoproteins based on their activation by tumor-promoting phorbol esters. However, accumulating evidence indicates that PKCs can be inhibitory in some cancers, with recent findings propelling a shift in focus to understanding tumor suppressive functions of these enzymes. Here, we report that PKCα acts as a tumor suppressor in PI3K/AKT-driven endometrial cancer. Transcriptional suppression of PKCα is observed in human endometrial tumors in association with aggressive disease and poor prognosis. In murine models, loss of PKCα is rate limiting for endometrial tumor initiation. PKCα tumor suppression involves PP2A-family-dependent inactivation of AKT, which can occur even in the context of genetic hyperactivation of PI3K/AKT signaling by coincident mutations in PTEN, PIK3CA, and/or PIK3R1. Together, our data point to PKCα as a crucial tumor suppressor in the endometrium, with deregulation of a PKCα→PP2A/PP2A-like phosphatase signaling axis contributing to robust AKT activation and enhanced endometrial tumorigenesis. Hsu et al. find that PKCα is frequently lost in human and murine endometrial tumors and that PKCα deficiency enhances PI3K/AKT-driven endometrial neoplasia. PKCα suppresses aberrant AKT activity via a PP2A family phosphatase-dependent mechanism. Thus, PKCα loss appears to cooperate with PI3K/AKT perturbations to hyperactivate AKT and promote endometrial tumorigenesis.",
keywords = "AKT, Id1, PI3K, PKC, PKCα, PP2A family, PTEN, endometrial cancer, endometrium, tumor suppression",
author = "Hsu, {Alice H.} and Lum, {Michelle A.} and Shim, {Kang Sup} and Frederick, {Peter J.} and Morrison, {Carl D.} and Baojiang Chen and Lele, {Subodh M} and Sheinin, {Yuri M.} and Takiko Daikoku and Dey, {Sudhansu K.} and Gustavo Leone and Black, {Adrian R} and Black, {Jennifer D}",
year = "2018",
month = "7",
day = "17",
doi = "10.1016/j.celrep.2018.06.067",
language = "English (US)",
volume = "24",
pages = "655--669",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium

AU - Hsu, Alice H.

AU - Lum, Michelle A.

AU - Shim, Kang Sup

AU - Frederick, Peter J.

AU - Morrison, Carl D.

AU - Chen, Baojiang

AU - Lele, Subodh M

AU - Sheinin, Yuri M.

AU - Daikoku, Takiko

AU - Dey, Sudhansu K.

AU - Leone, Gustavo

AU - Black, Adrian R

AU - Black, Jennifer D

PY - 2018/7/17

Y1 - 2018/7/17

N2 - Protein kinase C (PKC) isozymes are commonly recognized as oncoproteins based on their activation by tumor-promoting phorbol esters. However, accumulating evidence indicates that PKCs can be inhibitory in some cancers, with recent findings propelling a shift in focus to understanding tumor suppressive functions of these enzymes. Here, we report that PKCα acts as a tumor suppressor in PI3K/AKT-driven endometrial cancer. Transcriptional suppression of PKCα is observed in human endometrial tumors in association with aggressive disease and poor prognosis. In murine models, loss of PKCα is rate limiting for endometrial tumor initiation. PKCα tumor suppression involves PP2A-family-dependent inactivation of AKT, which can occur even in the context of genetic hyperactivation of PI3K/AKT signaling by coincident mutations in PTEN, PIK3CA, and/or PIK3R1. Together, our data point to PKCα as a crucial tumor suppressor in the endometrium, with deregulation of a PKCα→PP2A/PP2A-like phosphatase signaling axis contributing to robust AKT activation and enhanced endometrial tumorigenesis. Hsu et al. find that PKCα is frequently lost in human and murine endometrial tumors and that PKCα deficiency enhances PI3K/AKT-driven endometrial neoplasia. PKCα suppresses aberrant AKT activity via a PP2A family phosphatase-dependent mechanism. Thus, PKCα loss appears to cooperate with PI3K/AKT perturbations to hyperactivate AKT and promote endometrial tumorigenesis.

AB - Protein kinase C (PKC) isozymes are commonly recognized as oncoproteins based on their activation by tumor-promoting phorbol esters. However, accumulating evidence indicates that PKCs can be inhibitory in some cancers, with recent findings propelling a shift in focus to understanding tumor suppressive functions of these enzymes. Here, we report that PKCα acts as a tumor suppressor in PI3K/AKT-driven endometrial cancer. Transcriptional suppression of PKCα is observed in human endometrial tumors in association with aggressive disease and poor prognosis. In murine models, loss of PKCα is rate limiting for endometrial tumor initiation. PKCα tumor suppression involves PP2A-family-dependent inactivation of AKT, which can occur even in the context of genetic hyperactivation of PI3K/AKT signaling by coincident mutations in PTEN, PIK3CA, and/or PIK3R1. Together, our data point to PKCα as a crucial tumor suppressor in the endometrium, with deregulation of a PKCα→PP2A/PP2A-like phosphatase signaling axis contributing to robust AKT activation and enhanced endometrial tumorigenesis. Hsu et al. find that PKCα is frequently lost in human and murine endometrial tumors and that PKCα deficiency enhances PI3K/AKT-driven endometrial neoplasia. PKCα suppresses aberrant AKT activity via a PP2A family phosphatase-dependent mechanism. Thus, PKCα loss appears to cooperate with PI3K/AKT perturbations to hyperactivate AKT and promote endometrial tumorigenesis.

KW - AKT

KW - Id1

KW - PI3K

KW - PKC

KW - PKCα

KW - PP2A family

KW - PTEN

KW - endometrial cancer

KW - endometrium

KW - tumor suppression

UR - http://www.scopus.com/inward/record.url?scp=85049825453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049825453&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2018.06.067

DO - 10.1016/j.celrep.2018.06.067

M3 - Article

C2 - 30021163

AN - SCOPUS:85049825453

VL - 24

SP - 655

EP - 669

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 3

ER -